We know how unsettling this everchanging COVID-19 situation is and are here to support you as you make decisions about your care or the care of your loved ones. Our offices are committed to the health and safety of our community and have implemented rigorous policies and procedures to limit the exposure risks of any individual visiting our clinics. Don’t delay on getting a second opinion. Call us or fill out the form on this page, and a Prostate Cancer Patient Navigator will call you.
CyberKnife is a form of high-dose radiation treatment for prostate and other forms of cancer. CyberKnife’s unique robotic arm delivers Stereoactic Body Radiation Therapy (SBRT) to the prostate while compensating for movements of the prostate and, theoretically, protecting nearby tissue. The movement of the prostate is tracked through three to five tiny gold seeds known as fiducial markers that are inserted in the prostate through ultrasound-guided needles prior to radiation treatment. Treatment duration is normally four to five days. CyberKnife is a relatively new treatment method, and clinic trials are underway to determine CyberKnife’s long-term effectiveness and proper dosage levels.
If you have been recently diagnosed with prostate cancer, it’s critical to personally research prostate cancer treatment options to make an informed decision that is best for you and your family. And, with few exceptions, your first treatment generally gives you the best chance for success.
ProstRcision® has high documented disease-free survival rates using the strictest definition (PSA less than 0.2 ng/ml, 10 years after treatment). This unique approach to eradicating prostate cancer preserves sexual function and maintains urinary control for the vast majority of men. The documented 10-year and 15-year high disease-free survival rates, combined with no cutting of the prostate, and very few side effects are why over 16,000 men from all 50 states, and over 40 countries have chosen ProstRcision.
Call Joe Hall at 844-863-5518 to learn more about his prostate cancer journey.
Joe’s an 11-year prostate cancer survivor and disease-free.